Genentech

    OverviewSuggest Edit

    We live in an age of incredible scientific discovery. Scientists can now sequence entire human genomes in just hours. They can turn skin cells into heart cells and can create computer chips that mimic how the brain works. If your goal is to pair this type of world-class science with real human impact, there is no better place in the world to be than Genentech. Every day, our teams work to solve some of the hardest biomedical problems in the history of mankind, always with the goal of putting patients first. To do this, we become more than just scientists. We become explorers. We become pioneering drug discoverers. And as drug discoverers, we are never afraid of the unknown. In fact, we are attracted to it. Being a scientist at Genentech means living 10 years in the future and discovering transformative medicines for the people who need them.
    TypePrivate
    Founded1976
    HQSouth San Francisco, US
    Websitegene.com
    Employee Ratings3.9

    Latest Updates

    Employees (est.) (Nov 2019)21,835
    Job Openings473

    Genentech Office Locations

    Genentech has offices in South San Francisco, Hillsboro, Oceanside and Vacaville
    South San Francisco, US (HQ)
    1 DNA Way
    Hillsboro, US
    4625 NW Brookwood Pkwy
    Oceanside, US
    1 Antibody Way
    Vacaville, US
    1000 New Horizons Way
    Show all (4)

    Genentech Financials and Metrics

    Summary Metrics

    Founding Date

    1976

    Genentech Online and Social Media Presence

    Embed Graph

    Genentech News and Updates

    Sosei Heptares to Receive US$3 Million Payment from Genentech on Nomination of a New GPCR Disease Target

    TOKYO and LONDON, Oct. 9, 2019 /PRNewswire/ -- Sosei Group Corporation ("the Company"; TSE: 4565) announces that it has been notified by its partner Genentech, a member of the Roche Group, of its desire to nominate a new G protein-coupled receptor (GPCR) disease target, which has...

    Gilead Sciences names chief medical officer, from Genentech

    Gilead Sciences Inc. said Monday it named Merdad Parsey its chief medical officer, effective Nov. 1. Parsey was most recently a senior vice president of early clinical development at Roche Holding AG's Genentech Inc. Merdad will report directly to Chief Executive Daniel O'Day. The biopharmaceutica…

    Enable Injections Enters into Strategic Partnership with Genentech, a Member of the Roche Group

    CINCINNATI, Aug. 21, 2019 /PRNewswire/ -- Enable Injections, Inc. (Enable), a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group....

    CORRECTED-BRIEF-Convelo Therapeutics Enters Worldwide Collaboration with Genentech

    * CONVELO THERAPEUTICS ENTERS INTO COLLABORATION AND OPTION TO ACQUIRE AGREEMENT WITH GENENTECH TO DISCOVER NOVEL REMYELINATING THERAPIES

    Was The $47 Billion Acquisition of Genentech In 2009 A Good Deal For Roche?

    Roche Holding (NASDAQ:RHHBY) acquired Genentech, a pharmaceuticals company with three blockbuster oncology drugs, in 2009 for a sum of $47 billion. Back in 2008, Genentech’s top drugs were Avastin, Rituxan, Herceptin, and Lucentis, which generated sales of over $7 billion. As of 2018, the same ...

    Nancy Vitale of Genentech Joins Better™ to Reveal the DNA of Innovative Great Workplace Culture

    OAKLAND, Calif., June 25, 2019 /PRNewswire/ -- Great Place to Work®, the global authority on high trust workplace culture, recently unveiled Better™, a new podcast series of interviews with some of the best leaders in business. In the third episode, Nancy Vitale, the Senior Vice President ...
    Show more

    Genentech Blogs

    Understanding Lupus Nephritis

    Learn about this potentially life-threatening complication of systemic lupus erythematosus (SLE) that impacts the kidneys....

    It Takes a Village

    The search to treat Huntington’s disease has taken an international collaboration of families, scientists, fundraisers and advocates....

    Breast Cancer Treatment Basics

    Treatment approaches for early and metastatic breast cancer vary and are evaluated in unique ways....

    Giving and Getting Advice

    Carla Boragno shares the value of mentoring....

    Time is Brain

    When it comes to stroke, every second counts. Learn more about how to “BE FAST” from Lauren....

    Building Community Health

    Dr Sandy Escobar is transforming healthcare in East Palo Alto, one family at a time....
    Show more

    Genentech Frequently Asked Questions

    • When was Genentech founded?

      Genentech was founded in 1976.

    • How many employees does Genentech have?

      Genentech has 21,835 employees.

    • Who are Genentech competitors?

      Competitors of Genentech include CVS Health, Loxo Oncology and Keryx Biopharmaceuticals.

    • Where is Genentech headquarters?

      Genentech headquarters is located at 1 DNA Way, South San Francisco.

    • Where are Genentech offices?

      Genentech has offices in South San Francisco, Hillsboro, Oceanside and Vacaville.

    • How many offices does Genentech have?

      Genentech has 4 offices.